HEADER TRANSFERASE/INIHIBITOR 13-MAY-20 7C3N TITLE CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH DELGOCITINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 3,JAK-3,LEUKOCYTE JANUS KINASE,L-JAK; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, TRANSFERASE, TRANSFERASE-INIHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.DOI,T.OTIRA,M.KIKUWAKA,A.NOMURA,S.NOJI,T.ADACHI REVDAT 3 29-NOV-23 7C3N 1 REMARK REVDAT 2 22-JUL-20 7C3N 1 JRNL REVDAT 1 24-JUN-20 7C3N 0 JRNL AUTH S.NOJI,Y.HARA,T.MIURA,H.YAMANAKA,K.MAEDA,A.HORI,H.YAMAMOTO, JRNL AUTH 2 S.OBIKA,M.INOUE,Y.HASE,T.ORITA,S.DOI,T.ADACHI,A.TANIMOTO, JRNL AUTH 3 C.OKI,Y.KIMOTO,Y.OGAWA,T.NEGORO,H.HASHIMOTO,M.SHIOZAKI JRNL TITL DISCOVERY OF A JANUS KINASE INHIBITOR BEARING A HIGHLY JRNL TITL 2 THREE-DIMENSIONAL SPIRO SCAFFOLD: JTE-052 (DELGOCITINIB) AS JRNL TITL 3 A NEW DERMATOLOGICAL AGENT TO TREAT INFLAMMATORY SKIN JRNL TITL 4 DISORDERS. JRNL REF J.MED.CHEM. V. 63 7163 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32511913 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00450 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17_3644 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 20348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1021 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.2400 - 3.7900 1.00 3009 170 0.1605 0.1660 REMARK 3 2 3.7900 - 3.0100 1.00 2884 162 0.1523 0.1705 REMARK 3 3 3.0100 - 2.6300 1.00 2873 147 0.1779 0.2277 REMARK 3 4 2.6300 - 2.3900 1.00 2859 127 0.1831 0.2149 REMARK 3 5 2.3900 - 2.2200 0.95 2693 145 0.1787 0.2110 REMARK 3 6 2.2200 - 2.0800 0.92 2595 141 0.1751 0.2225 REMARK 3 7 2.0800 - 1.9800 0.86 2414 129 0.1956 0.2885 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.182 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.527 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2523 REMARK 3 ANGLE : 0.489 3437 REMARK 3 CHIRALITY : 0.041 358 REMARK 3 PLANARITY : 0.002 452 REMARK 3 DIHEDRAL : 24.564 970 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 814 THROUGH 861 ) REMARK 3 ORIGIN FOR THE GROUP (A): 20.1542 -2.8361 23.0594 REMARK 3 T TENSOR REMARK 3 T11: 0.1951 T22: 0.2435 REMARK 3 T33: 0.2478 T12: 0.0005 REMARK 3 T13: 0.0220 T23: -0.0189 REMARK 3 L TENSOR REMARK 3 L11: 3.0429 L22: 3.0706 REMARK 3 L33: 1.8873 L12: -0.2916 REMARK 3 L13: -0.4357 L23: 1.2600 REMARK 3 S TENSOR REMARK 3 S11: 0.0491 S12: 0.2887 S13: 0.2318 REMARK 3 S21: -0.3788 S22: -0.0365 S23: -0.3777 REMARK 3 S31: -0.1724 S32: 0.1414 S33: 0.0184 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 862 THROUGH 1102 ) REMARK 3 ORIGIN FOR THE GROUP (A): -1.5872 7.2884 30.7115 REMARK 3 T TENSOR REMARK 3 T11: 0.1464 T22: 0.1058 REMARK 3 T33: 0.0927 T12: -0.0079 REMARK 3 T13: 0.0172 T23: -0.0152 REMARK 3 L TENSOR REMARK 3 L11: 1.3823 L22: 1.2664 REMARK 3 L33: 0.6280 L12: -0.3681 REMARK 3 L13: 0.1254 L23: -0.0716 REMARK 3 S TENSOR REMARK 3 S11: 0.0059 S12: 0.0957 S13: -0.0156 REMARK 3 S21: -0.0079 S22: -0.0009 S23: -0.0033 REMARK 3 S31: -0.0284 S32: -0.0087 S33: -0.0126 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7C3N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1300016964. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 1.14.10 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20398 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 45.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.17500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.7.02 REMARK 200 STARTING MODEL: 1YVJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM PIPES PH6.0, 1.1M SODIUM REMARK 280 MALONATE, 1.6% GLYCEROL, 10MM DTT, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.89100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.82300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.70450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.82300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.89100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.70450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 810 REMARK 465 SER A 811 REMARK 465 GLN A 812 REMARK 465 ASP A 813 REMARK 465 ARG A 1103 REMARK 465 GLY A 1104 REMARK 465 CYS A 1105 REMARK 465 GLU A 1106 REMARK 465 THR A 1107 REMARK 465 HIS A 1108 REMARK 465 ALA A 1109 REMARK 465 PHE A 1110 REMARK 465 THR A 1111 REMARK 465 ALA A 1112 REMARK 465 HIS A 1113 REMARK 465 PRO A 1114 REMARK 465 GLU A 1115 REMARK 465 GLY A 1116 REMARK 465 LYS A 1117 REMARK 465 HIS A 1118 REMARK 465 HIS A 1119 REMARK 465 SER A 1120 REMARK 465 LEU A 1121 REMARK 465 SER A 1122 REMARK 465 PHE A 1123 REMARK 465 SER A 1124 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 832 -116.17 58.65 REMARK 500 ASP A 949 35.71 -148.11 REMARK 500 ALA A 966 14.21 -140.24 REMARK 500 ASP A1043 36.70 -90.82 REMARK 500 ALA A1065 -2.88 69.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A9367 DISTANCE = 6.26 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FHX A 9000 DBREF 7C3N A 812 1124 UNP P52333 JAK3_HUMAN 812 1124 SEQADV 7C3N GLY A 810 UNP P52333 EXPRESSION TAG SEQADV 7C3N SER A 811 UNP P52333 EXPRESSION TAG SEQRES 1 A 315 GLY SER GLN ASP PRO THR ILE PHE GLU GLU ARG HIS LEU SEQRES 2 A 315 LYS TYR ILE SER GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 A 315 VAL GLU LEU CYS ARG TYR ASP PRO LEU GLY ASP ASN THR SEQRES 4 A 315 GLY ALA LEU VAL ALA VAL LYS GLN LEU GLN HIS SER GLY SEQRES 5 A 315 PRO ASP GLN GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE SEQRES 6 A 315 LEU LYS ALA LEU HIS SER ASP PHE ILE VAL LYS TYR ARG SEQRES 7 A 315 GLY VAL SER TYR GLY PRO GLY ARG GLN SER LEU ARG LEU SEQRES 8 A 315 VAL MET GLU TYR LEU PRO SER GLY CYS LEU ARG ASP PHE SEQRES 9 A 315 LEU GLN ARG HIS ARG ALA ARG LEU ASP ALA SER ARG LEU SEQRES 10 A 315 LEU LEU TYR SER SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 A 315 LEU GLY SER ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA SEQRES 12 A 315 ARG ASN ILE LEU VAL GLU SER GLU ALA HIS VAL LYS ILE SEQRES 13 A 315 ALA ASP PHE GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS SEQRES 14 A 315 ASP PTR PTR VAL VAL ARG GLU PRO GLY GLN SER PRO ILE SEQRES 15 A 315 PHE TRP TYR ALA PRO GLU SER LEU SER ASP ASN ILE PHE SEQRES 16 A 315 SER ARG GLN SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 A 315 TYR GLU LEU PHE THR TYR CYS ASP LYS SER CYS SER PRO SEQRES 18 A 315 SER ALA GLU PHE LEU ARG MET MET GLY CYS GLU ARG ASP SEQRES 19 A 315 VAL PRO ALA LEU CYS ARG LEU LEU GLU LEU LEU GLU GLU SEQRES 20 A 315 GLY GLN ARG LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU SEQRES 21 A 315 VAL HIS GLU LEU MET LYS LEU CYS TRP ALA PRO SER PRO SEQRES 22 A 315 GLN ASP ARG PRO SER PHE SER ALA LEU GLY PRO GLN LEU SEQRES 23 A 315 ASP MET LEU TRP SER GLY SER ARG GLY CYS GLU THR HIS SEQRES 24 A 315 ALA PHE THR ALA HIS PRO GLU GLY LYS HIS HIS SER LEU SEQRES 25 A 315 SER PHE SER MODRES 7C3N PTR A 980 TYR MODIFIED RESIDUE MODRES 7C3N PTR A 981 TYR MODIFIED RESIDUE HET PTR A 980 16 HET PTR A 981 16 HET FHX A9000 23 HETNAM PTR O-PHOSPHOTYROSINE HETNAM FHX 3-[(3S,4R)-3-METHYL-7-(7H-PYRROLO[2,3-D]PYRIMIDIN-4- HETNAM 2 FHX YL)-1,7-DIAZASPIRO[3.4]OCTAN-1-YL]-3-OXIDANYLIDENE- HETNAM 3 FHX PROPANENITRILE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 FHX C16 H18 N6 O FORMUL 3 HOH *267(H2 O) HELIX 1 AA1 GLU A 818 ARG A 820 5 3 HELIX 2 AA2 GLY A 861 LEU A 878 1 18 HELIX 3 AA3 PRO A 893 GLN A 896 5 4 HELIX 4 AA4 CYS A 909 ARG A 918 1 10 HELIX 5 AA5 ALA A 919 LEU A 921 5 3 HELIX 6 AA6 ASP A 922 ARG A 943 1 22 HELIX 7 AA7 ALA A 951 ARG A 953 5 3 HELIX 8 AA8 PRO A 990 TYR A 994 5 5 HELIX 9 AA9 ALA A 995 ASN A 1002 1 8 HELIX 10 AB1 ARG A 1006 THR A 1022 1 17 HELIX 11 AB2 ASP A 1025 CYS A 1028 5 4 HELIX 12 AB3 SER A 1029 GLY A 1039 1 11 HELIX 13 AB4 PRO A 1045 GLU A 1056 1 12 HELIX 14 AB5 PRO A 1067 TRP A 1078 1 12 HELIX 15 AB6 SER A 1081 ARG A 1085 5 5 HELIX 16 AB7 SER A 1087 SER A 1102 1 16 SHEET 1 AA1 5 LEU A 822 GLY A 831 0 SHEET 2 AA1 5 GLY A 834 TYR A 841 -1 O LEU A 838 N SER A 826 SHEET 3 AA1 5 ALA A 850 LEU A 857 -1 O VAL A 852 N CYS A 839 SHEET 4 AA1 5 LEU A 898 GLU A 903 -1 O MET A 902 N ALA A 853 SHEET 5 AA1 5 TYR A 886 TYR A 891 -1 N GLY A 888 O VAL A 901 SHEET 1 AA2 2 CYS A 945 VAL A 946 0 SHEET 2 AA2 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 AA3 2 ILE A 955 SER A 959 0 SHEET 2 AA3 2 HIS A 962 ILE A 965 -1 O LYS A 964 N LEU A 956 SHEET 1 AA4 2 PTR A 980 VAL A 982 0 SHEET 2 AA4 2 ILE A1003 SER A1005 -1 O PHE A1004 N PTR A 981 LINK C ASP A 979 N PTR A 980 1555 1555 1.33 LINK C PTR A 980 N PTR A 981 1555 1555 1.33 LINK C PTR A 981 N VAL A 982 1555 1555 1.33 SITE 1 AC1 16 LEU A 828 GLY A 829 LYS A 830 GLY A 831 SITE 2 AC1 16 GLY A 834 SER A 835 VAL A 836 ALA A 853 SITE 3 AC1 16 GLU A 903 TYR A 904 LEU A 905 ARG A 953 SITE 4 AC1 16 ASN A 954 LEU A 956 ASP A 967 HOH A9199 CRYST1 53.782 65.409 83.646 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018594 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015288 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011955 0.00000